Please use this identifier to cite or link to this item:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/1024| Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection | |
| Zhang, B Liu, S Tan, T Huang, W Dong, Y Chen, L Chen, Q Zhang, L Zhong, Q Zhang, X Zou, Y Zhang, S | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for 379,661 infection cases with 16,428 deaths globally and the number is still increasing rapidly. Herein, we presented four critically ill patients with SARS-CoV-2 infection who received supportive care and convalescent plasma. Although all the four patients (including a pregnant woman) recovered from SARS-CoV-2 infection eventually, randomized trials are needed to eliminate the effect of other treatments and investigate the safety and efficacy of convalescent plasma therapy. | |
| Chest (American College of Chest Physicians) | |
| 2020 | |
| Preimpreso | |
| https://coronavirus.1science.com/item/c7ac698760db28705e645a68f7214f1776cfc8c1 | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Appears in Collections: | Artículos científicos |
Upload archives
| File | Size | Format | |
|---|---|---|---|
| 104691.pdf | 294 kB | Adobe PDF | View/Open |